These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27776922)

  • 81. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy.
    Esper CD; Freeman A; Factor SA
    Parkinsonism Relat Disord; 2010 Aug; 16(7):438-41. PubMed ID: 20494607
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach.
    Moscovich M; Chen ZP; Rodriguez R
    J Clin Neurosci; 2015 Mar; 22(3):594-6. PubMed ID: 25541097
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Botulinum toxin type A treatment of four cases of Wilson disease with lower limb dystonia: A prospective study.
    Cao Z; Rao R; Wu T; Chen S; Xing S; Han Y
    Toxicon; 2023 Jan; 221():106959. PubMed ID: 36343759
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Botulinum Toxin in Secondarily Nonresponsive Patients with Spasmodic Dysphonia.
    Mor N; Tang C; Blitzer A
    Otolaryngol Head Neck Surg; 2016 Sep; 155(3):458-61. PubMed ID: 27143711
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Exploring the Psychosocial Impact of Botulinum Toxin Type A Injections for Individuals With Oromandibular Dystonia: A Qualitative Study of Patients' Experiences.
    Page AD; Elhayek N; Baylor C; Adams S; Jog M; Yorkston K
    Am J Speech Lang Pathol; 2021 Jun; 30(3S):1314-1328. PubMed ID: 33647215
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Adult-onset focal dystonias: presentation and treatment options.
    Esper GJ; Charles PD; Davis TL; Robertson D
    Tenn Med; 1997 Jan; 90(1):18-20. PubMed ID: 8997156
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Dynamics of quality-of-life in patients with torticollis treated with botulinum toxin A].
    Likhachev SA; Gavrilenko LN; Chernukha TN; Rushkevich IuN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(4):30-5. PubMed ID: 19491807
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Subcutaneous Botulinum Toxin Injection for Post-Thoracotomy Pain Syndrome in Palliative Care: A Case Report.
    Rashid S; Fields AR; Baumrucker SJ
    Am J Hosp Palliat Care; 2018 Mar; 35(3):511-513. PubMed ID: 28641445
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia.
    Dressler D; Kupsch A; Seitzinger A; Paus S
    Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A case of idiopathic lower limb dystonia treated with combined botulinum toxin and phenol nerve block.
    Bianchini E; Massimiani A; Bemporad J; Giovannelli M
    Acta Neurol Belg; 2024 Jun; 124(3):1095-1097. PubMed ID: 38133850
    [No Abstract]   [Full Text] [Related]  

  • 92. Is Botulinum Toxin Type A Efficacious, Safe, and Tolerable in Cervical Dystonia?: A Cochrane Review Summary With Commentary.
    Oral A
    Am J Phys Med Rehabil; 2020 Jul; 99(7):649-651. PubMed ID: 32251106
    [No Abstract]   [Full Text] [Related]  

  • 93. The Effect of Botulinum Toxin on Network Connectivity in Cervical Dystonia: Lessons from Magnetoencephalography.
    Mahajan A; Alshammaa A; Zillgitt A; Bowyer SM; LeWitt P; Kaminski P; Sidiropoulos C
    Tremor Other Hyperkinet Mov (N Y); 2017; 7():502. PubMed ID: 29204314
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clinical comparability of marketed formulations of botulinum toxin.
    Sampaio C; Costa J; Ferreira JJ
    Mov Disord; 2004 Mar; 19 Suppl 8():S129-36. PubMed ID: 15027065
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Treatment of neck pain with type A botulinum toxin evaluated by Neck Pain Questionnaire (NPQ).
    Crestani F; Muftah Shaladi A; Saltari R; Gozza C; Michielan F
    Clin Ter; 2013; 164(4):e279-82. PubMed ID: 24045523
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Bilateral Lower Sternocleidomastoid Botulinum Toxin Injections to Address Refractory Anterocollis.
    Peng-Chen Z; Thompson A; Rodriguez RL
    Neurologist; 2016 Mar; 21(2):30-1. PubMed ID: 26926853
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Oromandibular dystonia in yemeni patients with khat chewing: a response to botulinum toxin treatment.
    Shehata HS; El-Tamawy MS; Mohieldin N; Edrees M; Bohlega S
    Neurol Int; 2014 Apr; 6(2):5385. PubMed ID: 24987506
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 99. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The Central Effects of Botulinum Toxin in Dystonia and Spasticity.
    Hok P; Veverka T; Hluštík P; Nevrlý M; Kaňovský P
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33671128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.